Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis

References

• Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–e322.
   PubMed Web of Science ®Google Scholar
• Townsend N, Nichols M, Scarborough P, et al. Cardiovascular disease in Europe 2015: epidemiological update. Eur Heart J. 2015;36(40):2696–2705.
   PubMed Web of Science ®Google Scholar
• Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25.
   PubMed Web of Science ®Google Scholar
• Aouba AJ, Eb M, Rey G. L’évolution de la mortalité et des causes de décès entre 1990 et 2009. Actualité et Dossier en Santé Publique. 2012;80:24–28.
   Google Scholar
• Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Eur Heart J. 2018;39(9):763–816.
   PubMed Web of Science ®Google Scholar
• Hosaka A, Miyata T, Onishi Y, et al. Clinical and economic burden in patients with diagnosis of peripheral arterial disease in a claims database in Japan. Clin Ther. 2014;36(8):1223–1230, 1230 e1221–1224.
   PubMed Web of Science ®Google Scholar
• Nehler MR, Duval S, Diao L, et al. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg. 2014;60(3):686–695.
   PubMed Web of Science ®Google Scholar
• Marrett E, DiBonaventura M, Zhang Q. Burden of peripheral arterial disease in Europe and the United States: a patient survey. Health Qual Life Outcomes. 2013;11(1):175.
   PubMedGoogle Scholar
• Margolis J, Barron JJ, Grochulski WD. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data. JMCP. 2005;11(9):727–734.
   PubMedGoogle Scholar
• Mahoney EM, on behalf of the Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators*, Wang K, Keo HH, et al. Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States. Circ Cardiovasc Qual Outcomes. 2010;3(6):642–651.
   PubMed Web of Science ®Google Scholar
• Fowkes FG, Aboyans V, Fowkes FJ, et al. Peripheral artery disease: epidemiology and global perspectives. Nat Rev Cardiol. 2017;14(3):156–170.
   PubMed Web of Science ®Google Scholar
• Hiatt WR, Rogers RK. The treatment gap in peripheral artery disease. J Am Coll Cardiol. 2017;69(18):2301–2303.
   PubMed Web of Science ®Google Scholar
• Berger JS, Ladapo JA. Underuse of prevention and lifestyle counseling in patients with peripheral artery disease. J Am Coll Cardiol. 2017;69(18):2293–2300.
   PubMed Web of Science ®Google Scholar
• Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295(2):180–189.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Summary of opinion (post authorisation): Xarelto. 2018. (EMA/CHMP/515065/2018). [cited 27 September 2019] Available from: https://www.ema.europa.eu/documents/smop/chmp-post-authorisation-summary-positive-opinion-xarelto-ii-58_en.pdf.
   Google Scholar
• Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med. 2017;377(14):1319–1330.
   PubMed Web of Science ®Google Scholar
• Anand SS, Bosch J, Eikelboom JW, et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2018;391(10117):219–229.
   PubMed Web of Science ®Google Scholar
• Hiatt WR, Rogers RK. The development of therapeutics for peripheral artery disease: a unique cardiovascular risk population. J Am Coll Cardiol. 2016;67(23):2729–2731.
   PubMed Web of Science ®Google Scholar
• Tuppin P, Rudant J, Constantinou P, et al. Value of a national administrative database to guide public decisions: From the systeme national d’information interregimes de l’Assurance Maladie (SNIIRAM) to the systeme national des donnees de sante (SNDS) in France. Rev Epidemiol Sante Publique. 2017;65 (Suppl 4):S149–S167.
   PubMedGoogle Scholar
• Haute Autorité de Santé. Choices in methods for economic evaluation. 2012. [cited 27 September 2019] Available from: https://www.has-sante.fr/upload/docs/application/pdf/2012-10/choices_in_methods_for_economic_evaluation.pdf.
   Google Scholar
• Darmon A, Bhatt DL, Elbez Y, et al. External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry. Eur Heart J. 2018;39(9):750–757a.
   PubMed Web of Science ®Google Scholar
• Tuppin P, Riviere S, Rigault A, et al. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database. Arch Cardiovasc Dis. 2016;109(6-7):399–411.
   PubMed Web of Science ®Google Scholar
• Smolderen KG, Wang K, de Pouvourville G, et al. Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease. Eur J Vasc Endovasc Surg. 2012;43(2):198–207.
   PubMed Web of Science ®Google Scholar
• Bosco-Lévy P, Duret S, Picard F, et al. Diagnostic accuracy of the International Classification of Diseases, Tenth Revision, codes of heart failure in an administrative database. Pharmacoepidemiol Drug Saf. 2019;28(2):194–200.
   PubMed Web of Science ®Google Scholar
• Prat M, Derumeaux H, Sailler L, et al. Positive predictive values of peripheral arterial and venous thrombosis codes in French hospital database. Fundam Clin Pharmacol. 2018;32(1):108–113.
   PubMed Web of Science ®Google Scholar
• Bezin J, Girodet PO, Rambelomanana S, et al. Choice of ICD-10 codes for the identification of acute coronary syndrome in the French hospitalization database. Fundam Clin Pharmacol. 2015;29(6):586–591.
   PubMed Web of Science ®Google Scholar
• Cohen S, Jannot AS, Iserin L, et al. Accuracy of claim data in the identification and classification of adults with congenital heart diseases in electronic medical records. Arch Cardiovasc Dis. 2019;112(1):31–43.
   PubMed Web of Science ®Google Scholar